| 1 |
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen, Marion Koopmans, Unyeong Yu Go et al. · The Lancet Infectious Diseases
Open access |
3 Jul 2020 |
1,295 |
| 2 |
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Laura E. Via, Philana Ling Lin, Sonja M. Ray et al. · Infection and Immunity
Open access |
17 Mar 2008 |
666 |
| 3 |
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al. · The Lancet
ReviewOpen access108 authors |
Sep 2018 |
648 |
| 4 |
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al. · New England Journal of Medicine
Open access |
18 Oct 2012 |
565 |
| 5 |
Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
Seok-Yong Eum, Ji-Hye Kong, Min-Sun Hong et al. · CHEST Journal
Open access |
12 Sep 2009 |
556 |
| 6 |
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi, Xuelian Zhang, Xin Jiang et al. · Science
Open access |
12 Aug 2011 |
522 |
| 7 |
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux, Laura E. Via, Matthew D. Zimmerman et al. · Nature Medicine
Open access |
7 Sep 2015 |
486 |
| 8 |
Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
Joshua T. Mattila, Olabisi Olaniyi Ojo, Diane Kepka‐Lenhart et al. · The Journal of Immunology
Open access |
7 Jun 2013 |
359 |
| 9 |
High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
Thierry Christophe et al. · PLoS Pathogens
Open access |
29 Oct 2009 |
337 |
| 10 |
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T. Malherbe et al. · Nature Medicine
Open access |
5 Sep 2016 |
317 |
| 11 |
Inflammatory signaling in human tuberculosis granulomas is spatially organized
Mohlopheni Jackson Marakalala, Ravikiran M. Raju, Kirti Sharma et al. · Nature Medicine
Open access |
4 Apr 2016 |
315 |
| 12 |
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
Abigail L. Manson et al. · Nature Genetics
Open access |
16 Jan 2017 |
304 |
| 13 |
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Tracy L. Dalton, Peter Cegielski, Somsak Akksilp et al. · The Lancet
Open access |
29 Aug 2012 |
228 |
| 14 |
WHO global research priorities for antimicrobial resistance in human health
Silvia Bertagnolio et al. · The Lancet Microbe
Open access284 authors |
13 Aug 2024 |
217 |
| 15 |
Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
Natasha Strydom, Sneha V. Gupta, William S. Fox et al. · PLoS Medicine
Open access |
2 Apr 2019 |
207 |
| 16 |
Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis
Doh Hyung Kim, Hee Jin Kim, Seung-Kyu Park et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
14 Aug 2008 |
186 |
| 17 |
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
Ray Y. Chen et al. · Science Translational Medicine
Open access |
3 Dec 2014 |
162 |
| 18 |
High Persister Mutants in Mycobacterium tuberculosis
Heather L. Torrey, Iris Keren, Laura E. Via et al. · PLoS ONE
Open access |
13 May 2016 |
161 |
| 19 |
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study
Aditya Sharma et al. · The Lancet Infectious Diseases
Open access |
9 May 2017 |
155 |
| 20 |
Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
J. Peter Cegielski et al. · Clinical Infectious Diseases
Open access |
23 Jul 2014 |
150 |
| 21 |
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
Yingda L. Xie et al. · New England Journal of Medicine
Open access |
13 Sep 2017 |
147 |
| 22 |
Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis
Sharon Y. Wong, Jong Seok Lee, Hyun-Kyung Kwak et al. · Antimicrobial Agents and Chemotherapy
Open access |
29 Mar 2011 |
144 |
| 23 |
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Taeksun Song, Myungsun Lee, Han-Seung Jeon et al. · EBioMedicine
Open access |
15 Oct 2015 |
143 |
| 24 |
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
M. Teresa Coleman, Ray Y. Chen, Myungsun Lee et al. · Science Translational Medicine
Open access |
3 Dec 2014 |
137 |
| 25 |
Differential Virulence and Disease Progression following Mycobacterium tuberculosis Complex Infection of the Common Marmoset (Callithrix jacchus)
Laura E. Via et al. · Infection and Immunity
Open access |
29 May 2013 |
128 |
| 26 |
Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis
Jae Jin Lee, Sun‐Kyung Lee, Naomi Song et al. · Nature Communications
Open access |
2 Jul 2019 |
126 |
| 27 |
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
Mary P Choules et al. · Antimicrobial Agents and Chemotherapy
Open access |
3 Jan 2019 |
124 |
| 28 |
Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy
Michelle M. Bellerose, Seung-Hun Baek, Chuan‐Chin Huang et al. · mBio
Open access |
29 Jul 2019 |
122 |
| 29 |
Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
Jongseok Lee, Derek T. Armstrong, Willy Ssengooba et al. · Antimicrobial Agents and Chemotherapy
Open access |
7 Oct 2013 |
110 |
| 30 |
Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis
Jae‐Wook Lee, Si‐Hyun Kim, Dongsic Choi et al. · PROTEOMICS
|
23 Jul 2015 |
107 |
| 31 |
COVID-19–We urgently need to start developing an exit strategy
Eskild Petersen, Sean A Wasserman, Shui Shan Lee et al. · International Journal of Infectious Diseases
Open access |
28 Apr 2020 |
101 |
| 32 |
Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital
Christie Y. Jeon, Sung‐Hee Hwang, Jin Hong Min et al. · Clinical Infectious Diseases
Open access |
26 Dec 2007 |
101 |
| 33 |
Fitness costs of rifampicin resistance in M ycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β′ subunit of RNA polymerase
Taeksun Song et al. · Molecular Microbiology
Open access |
14 Jan 2014 |
99 |
| 34 |
Impact of Diabetes and Smoking on Mortality in Tuberculosis
George W Reed, Hongjo Choi, So Young Lee et al. · PLoS ONE
Open access |
28 Feb 2013 |
93 |
| 35 |
Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor
Harshini Mukundan, Sandeep Kumar, Dominique N. Price et al. · Tuberculosis
Open access |
18 Jun 2012 |
92 |
| 36 |
Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis
Matthew W. Carroll et al. · Antimicrobial Agents and Chemotherapy
Open access |
4 Jun 2013 |
83 |
| 37 |
Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach
Yonggeun Cho, Youngmok Park, Bora Sim et al. · Scientific Reports
Open access |
2 Mar 2020 |
77 |
| 38 |
Linezolid for XDR-TB — Final Study Outcomes
Myungsun Lee, Taeksun Song, Youngran Kim et al. · New England Journal of Medicine
Open access |
15 Jul 2015 |
77 |
| 39 |
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
Laura E. Via et al. · ACS Infectious Diseases
Open access |
17 Mar 2015 |
77 |
| 40 |
Genetic Diversity of Mycobacterium tuberculosis Isolates from a Tertiary Care Tuberculosis Hospital in South Korea
Isdore Chola Shamputa, Jongseok Lee, Caroline Allix‐Béguec et al. · Journal of Clinical Microbiology
Open access |
17 Dec 2009 |
75 |
| 41 |
Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012
Hongjo Choi, Myungsun Lee, Ray Y. Chen et al. · BMC Infectious Diseases
Open access |
2 Jul 2014 |
74 |
| 42 |
Polymorphisms Associated with Resistance and Cross-Resistance to Aminoglycosides and Capreomycin in Mycobacterium tuberculosis Isolates from South Korean Patients with Drug-Resistant Tuberculosis
Laura E. Via et al. · Journal of Clinical Microbiology
Open access |
24 Dec 2009 |
73 |
| 43 |
Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice
Guanghou Shui, Anne K. Bendt, Ignasius Aditya Jappar et al. · EMBO Molecular Medicine
Open access |
7 Dec 2011 |
69 |
| 44 |
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
Jeongha Mok et al. · The Lancet
Open access |
Oct 2022 |
68 |
| 45 |
Latent Tuberculosis: Two Centuries of Confusion.
Marcel A. Behr, Eva Kaufmann, Jacalyn M. Duffin et al. · Apollo (University of Cambridge)
Open access |
25 Jun 2021 |
65 |
| 46 |
Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort
Miles W. Carroll et al. · The International Journal of Tuberculosis and Lung Disease
Open access |
14 May 2012 |
64 |
| 47 |
Natural killer cells are recruited during pulmonary tuberculosis and theirex vivoresponses to mycobacteria vary between healthy human donors in association with KIR haplotype
Damien Portevin, Laura E. Via, Seok‐Yong Eum et al. · Cellular Microbiology
Open access |
13 Jul 2012 |
64 |
| 48 |
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use
Soumitesh Chakravorty et al. · Journal of Clinical Microbiology
Open access |
3 Nov 2016 |
58 |
| 49 |
Rapid Detection of Fluoroquinolone-Resistant and Heteroresistant Mycobacterium tuberculosis by Use of Sloppy Molecular Beacons and Dual Melting-Temperature Codes in a Real-Time PCR Assay
Soumitesh Chakravorty, Bola Aladegbami, Kimberley Thoms et al. · Journal of Clinical Microbiology
Open access |
30 Dec 2010 |
57 |
| 50 |
Exploring Alternative Biomaterials for Diagnosis of Pulmonary Tuberculosis in HIV-Negative Patients by Use of the GeneXpert MTB/RIF Assay
Shubhada Shenai, Danielle Amisano, Katharina Ronacher et al. · Journal of Clinical Microbiology
Open access |
10 Oct 2013 |
57 |